Cancer stem cells: are they responsible for treatment failure?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Future Oncology

• Publication date

  2014-11-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/fon.14.126PMID 25396775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting cancer stem cells to suppress acquired chemotherapy resistance

  2014cited by this paper
• TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

  2014cited by this paper
• Therapy‐induced enrichment of putative lung cancer stem‐like cells

  2014cited by this paper
• CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.

  2014cited by this paper
• Unraveling the therapeutic potential of the Hedgehog pathway in cancer

  2013cited by this paper
• A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.

  2013cited by this paper
• Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy.

  2013cited by this paper
• Targeting apoptosis pathways in cancer stem cells.

  2013cited by this paper
• Biological and clinical implications of cancer stem cells in primary brain tumors

  2013cited by this paper
• Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy.

  2013cited by this paper
• Development of PI3K inhibitors: lessons learned from early clinical trials

  2013cited by this paper
• TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer.

  2013cited by this paper
• BMP Signaling Induces Astrocytic Differentiation of Clinically Derived Oligodendroglioma Propagating Cells

  2013cited by this paper
• Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors

  2013cited by this paper
• CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy

  2013cited by this paper
• A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission

  2012cited by this paper
• Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.

  2012cited by this paper
• BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression

  2012cited by this paper
• Induction of pluripotent stem cell cells from germ cells

  2012cited by this paper
• A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells

  2012cited by this paper
• Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

  2012cited by this paper
• Proliferation State and Polo‐Like Kinase1 Dependence of Tumorigenic Colon Cancer Cells

  2012cited by this paper
• Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors.

  2012cited by this paper
• EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential

  2012cited by this paper
• Clonal evolution in cancer

  2012cited by this paper
• DNA Damage Repair Pathways in Cancer Stem Cells

  2012cited by this paper
• Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population.

  2012cited by this paper
• Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics.

  2011cited by this paper
• Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy

  2011cited by this paper
• Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell ‘stemness’ via the bone morphogenetic protein pathway

  2011cited by this paper
• Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.

  2011cited by this paper
• The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

  2011cited by this paper
• Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells

  2011cited by this paper
• Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.

  2011cited by this paper
• Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

  2011cited by this paper
• Genetic variegation of clonal architecture and propagating cells in leukaemia

  2011cited by this paper
• Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

  2011cited by this paper
• Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells

  2011cited by this paper
• Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition

  2011cited by this paper
• Inhibition of Ataxia Telangiectasia‐ and Rad3 ‐Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor‐Initiating Cell Fraction

  2011cited by this paper
• Acidic stress promotes a glioma stem cell phenotype

  2011cited by this paper
• Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients

  2011cited by this paper
• Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations.

  2011cited by this paper
• Cancer Stem Cells and Chemosensitivity

  2011cited by this paper
• BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment.

  2011cited by this paper
• Therapeutic Targeting of Cancer Stem Cells

  2011cited by this paper
• Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.

  2011cited by this paper
• Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence

  2011cited by this paper
• Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

  2011cited by this paper
• Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells

  2010cited by this paper
• Chronic DLL4 blockade induces vascular neoplasms

  2010cited by this paper
• Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.

  2010cited by this paper
• Glioblastoma stem-like cells give rise to tumour endothelium

  2010cited by this paper
• Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres

  2010cited by this paper
• Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

  2010cited by this paper
• CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells

  2010cited by this paper
• Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma

  2010cited by this paper
• New models for cancer research: human cancer stem cell xenografts.

  2010cited by this paper
• Tumorigenic and metastatic activity of human thyroid cancer stem cells.

  2010cited by this paper
• Heterogeneity in cancer: cancer stem cells versus clonal evolution.

  2009cited by this paper
• Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.

  2009cited by this paper
• Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

  2009cited by this paper
• NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts

  2009cited by this paper
• Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.

  2009cited by this paper
• Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

  2009cited by this paper
• Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

  2009cited by this paper
• Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution

  2009cited by this paper
• Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab

  2009cited by this paper
• Identification and expansion of the tumorigenic lung cancer stem cell population

  2008cited by this paper
• Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.

  2008cited by this paper
• Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.

  2008cited by this paper
• Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4

  2008cited by this paper
• Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.

  2008cited by this paper
• Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme

  2008cited by this paper
• Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition

  2008cited by this paper
• Molecular Cancer BioMed Central

  2008cited by this paper
• Efficient tumour formation by single human melanoma cells

  2008cited by this paper
• Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Mesenchymal differentiation of glioblastoma stem cells

  2008cited by this paper
• Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.

  2008cited by this paper
• Efficient tumor formation by single human melanoma cells

  2008cited by this paper
• Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

  2007cited by this paper
• Identification and expansion of human colon-cancer-initiating cells

  2007cited by this paper
• Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

  2007cited by this paper
• HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.

  2007cited by this paper
• The prognostic role of a gene signature from tumorigenic breast-cancer cells.

  2007cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• EXPRESSION OF UBIQUITIN-SPECIFIC PROTEASE 14 IN HUMAN PANCREATIC CANCER CELL LINES AND CANCER TISSUES

  2005cited by this paper
• A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma.

  2005cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study.

  2003cited by this paper
• Genome maintenance mechanisms for preventing cancer

  2001cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper

• AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.

  2020cites this paper
• Animal Models of Brain Tumor Surgery

  2019cites this paper
• Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia

  2018cites this paper
• Synergistic Anticancer Effects of Curcumin and Hinokitiol on Gefitinib Resistant Non-Small Cell Lung Cancer Cells

  2018cites this paper
• Unveiling heterogeneity: the pressing challenge to cancer diagnosis and therapy

  2018cites this paper
• LncRNA Miat Promotes Proliferation of Cervical Cancer Cells and Acts as an Anti-apoptotic Factor

  2017cites this paper
• The many faces of SRPK1†

  2017influential citation
• Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer

  2017cites this paper
• DNA Repair.

  2016cites this paper
• Radiation DNA damage and use in cancer/therapeutics-translation of radiation modifiers

  2016cites this paper
• Serine‐arginine protein kinase 1 promotes a cancer stem cell‐like phenotype through activation of Wnt/β‐catenin signalling in NSCLC

  2016cites this paper
• Endocytosis and serpentine filopodia drive blebbishield-mediated resurrection of apoptotic cancer stem cells

  2016cites this paper
• Biomarkers and signaling pathways of colorectal cancer stem cells

  2015cites this paper
• Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

  2015cites this paper